Nayanendu Saha - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Nayanendu Saha

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023

Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cellsNayanendu Saha, Du-San Baek, Rachelle P Mendoza, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 26, 2024

Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cellsNayanendu Saha, Sang Gyu Lee, Eeva-Christine Brockmann, et al.

The Journal of Experimental Medicine|August 10, 2016

An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growthLakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023

Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cellsNayanendu Saha, Du-San Baek, Rachelle P Mendoza, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 26, 2024

Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cellsNayanendu Saha, Sang Gyu Lee, Eeva-Christine Brockmann, et al.

The Journal of Experimental Medicine|August 10, 2016

An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growthLakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.

Pageof 3